HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lucio C Rovati Selected Research

Glucosamine (Dona)

12/2018Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
2/2016The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study.
2/2016Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
6/2012Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties.
1/2011Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials.
1/2011Experimental pharmacology of glucosamine sulfate.
11/2010Glucosamine and osteoarthritis. Conclusions not supported by methods and results.
2/2007The reverse glucosamine sulfate pathway: application in knee osteoarthritis.
3/2004Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies.
10/2002Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lucio C Rovati Research Topics

Disease

9Osteoarthritis
12/2018 - 03/2004
9Knee Osteoarthritis
02/2016 - 10/2002
4Pain (Aches)
12/2018 - 10/2002
2Neoplasms (Cancer)
01/2021 - 10/2010
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2006 - 05/2004
2Constipation
01/2006 - 05/2004
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Overweight
02/2016
1Non-alcoholic Fatty Liver Disease
01/2015
1Diarrhea
10/2010
1Mucositis
10/2010
1Inflammation (Inflammations)
10/2010
1Dyslipidemias (Dyslipidemia)
01/2007
1Gastroesophageal Reflux (GERD)
01/2006
1Renal Insufficiency (Renal Failure)
01/2006
1Dyspepsia (Indigestion)
01/2006
1Atherosclerosis
01/2005

Drug/Important Bio-Agent (IBA)

10Glucosamine (Dona)IBA
12/2018 - 10/2002
4Pharmaceutical PreparationsIBA
01/2021 - 01/2006
2Hyaluronic Acid (Hyaluronan)IBA
12/2018 - 09/2012
2CholesterolIBA
01/2011 - 01/2005
2astaxanthine (astaxanthin)IBA
01/2007 - 01/2005
2policosanolIBA
01/2007 - 01/2005
2dexloxiglumideIBA
01/2006 - 05/2004
2Cholecystokinin (Pancreozymin)IBA
01/2006 - 05/2004
1Phosphotransferases (Kinase)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018
1cindunistatIBA
12/2018
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2018
1Analgesics (Analgesic Drugs)IBA
12/2018
1Celecoxib (Celebrex)FDA Link
12/2018
1Diphosphonates (Bisphosphonates)IBA
12/2018
1AntioxidantsIBA
12/2018
1fibroblast growth factor 18IBA
12/2018
1strontium ranelate (protelos)IBA
12/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2016
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
02/2016
1Silybin (Lagosa)IBA
01/2015
1Prescription DrugsIBA
06/2012
1Glucose (Dextrose)FDA LinkGeneric
01/2011
1LipidsIBA
01/2011
1benzamidineIBA
10/2010
1Fluorouracil (Carac)FDA LinkGeneric
10/2010
1CR 3294IBA
10/2010
1SaltsIBA
02/2007
1BerberineIBA
01/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2007
1red yeast riceIBA
01/2005
1Biomarkers (Surrogate Marker)IBA
05/2003

Therapy/Procedure

1Intra-Articular Injections
12/2018
1Analgesia
02/2016
1Replacement Arthroplasty
08/2011
1Drug Therapy (Chemotherapy)
10/2010